Use of Hepatitis C Virus Positive Donor Organs in Hepatitis C Virus Uninfected Solid Organ Transplant Recipients

Nov 18 2024
Convention Center: Room 25 C
7:00 AM - 7:45 AM
Ticketed Event

World Class Speakers

David S. Goldberg, MD, MSCE
Discussion Leader

David S. Goldberg, MD, MSCE

University of Miami
JP
Discussion Leader

Jennifer Price, MD, PhD

Description

Using high-risk donors, including those who are infected with HCV, is a strategy to increase organ supply. The use of direct-acting antiviral therapy has paved the way for the use of HCV-viremic organs, changing the landscape of solid organ transplantation (SOT). Experts in this session review and discuss the data on the use of HCV-infected donor organs in SOT.  



 

Journey Maps

Objectives

  • Review and discuss the use of HCVpositive donor organs in HCVuninfected recipients in solid organ transplant (SOT).
  • Describe the challenges and ethical considerations regarding the use of HCV-positive organs in HCV-uninfected recipients.
  • Discuss the challenges and facilitators to implementing use of HCV-positive donor organs in HCV-uninfected SOT recipients as standard of care.
  • Review the positions of professional societies on the use of HCV-viremic donor organs in HCV-uninfected recipients.